SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc., (OTCBB:AEMD) a pioneer in developing therapeutic devices for infectious disease, announced today that its Chairman and CEO, James A. Joyce will present at the Friedland Capital Life Sciences Conference at 12pm PST, this Wednesday the 7th of February. In addition to providing a corporate update, Mr. Joyce will discuss new collaborations with researchers at The Centers for Disease Control (CDC), The United States Army Medical Research Institute of Infectious Diseases (USAMRIID), and the Government of India’s National Institute of Virology (NIV).
